The trademark ABATA was filed by Abata Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 25, 2021, and received one opposition filed on November 25, 2021 by MEIJI PHARMA SPAIN, S.A. on Likelihood of confusion. the opponent was represented by RYO RODRIGUEZ OCA, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 25, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 12, 2022. Change of name and address of the trademark registration was recorded on January 24, 2022. Appointment and Replacement of representative of the trademark registration was recorded on August 14, 2023. Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on July 1, 2024. Change of name and address of the trademark registration was recorded on July 14, 2024.
The Appeal with reference B R1265/2023-5 was Trade mark application refused according to Article 8(1)(b) EUTMIR with decision issued on January 22, 2024 by the EUIPO. The Opposition with reference B 003159043 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on April 17, 2023 by the EUIPO.